Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.9647
-0.0353 (-3.53%)
Feb 26, 2026, 2:57 PM EST - Market open
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $22.61 million as of February 26, 2026. Its market cap has decreased by -68.55% in one year.
Market Cap
22.61M
Enterprise Value
11.56M
1-Year Change
-68.55%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $22.61M, a decrease of -89.17%. That is a compound annual growth rate of -41.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 23.43M | -32.89% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 25.49M |
| Lixte Biotechnology Holdings | 25.27M |
| Hyperion DeFi | 25.11M |
| Marker Therapeutics | 24.51M |
| IO Biotech | 24.31M |
| Daré Bioscience | 23.72M |
| Barinthus Biotherapeutics | 23.69M |
| Exicure | 23.62M |